Abiopharma

🔍 Kahn Todd (Executive)

Company: TAPESTRY, INC. (TPR)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 11,626 shares of Common Stock at $129.02 per share (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 97,479.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,294 shares of Common Stock at $132.26 per share (Direct)
  Date: 2026-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 96,185.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 30,864 shares of Stock Option at $129.02 per share (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2036-08-17 | Exercise: 2027-08-17 | equity_swap_involved: 0 | shares_owned_after: 30,864.00 | transaction_form_type: 4 | Footnotes: F3, F4, F5

Footnotes:

• F1: These securities were acquired in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest in four equal tranches on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 17, 2027, the second on August 17, 2028, the third on August 17, 2029 and the fourth on August 17, 2030.
• F2: These shares were withheld to pay the taxes in connection with the vesting of restricted stock units.
• F3: These securities were issued under the Issuer's Stock Incentive Plan.
• F4: These securities will convert on a 1-for-1 basis into shares of the issuer's common stock.
• F5: These service-based securities vest in four equal installments on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 17, 2027, the second on August 17, 2028, the third on August 17, 2029 and the fourth on August 17, 2030.